An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism
Article in The Journal of Clinical Endocrinology & Metabolism (March 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in The Journal of Clinical Endocrinology & Metabolism (March 2024)
Article in Endocrine (December 2023)
Article in Frontiers in Pharmacology (July 2023)